newsfilter
← Latest News
Business Wire·

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

New management, led by David Meek, is committed to rapidly scaling access to lifechanging gene therapies Significant capital commitment from Carlyle and SK Capital will enable bluebird to grow and accelerate patient